PDB Short entry for 2JAI HEADER HYDROLASE 29-NOV-06 2JAI TITLE DDAH1 COMPLEXED WITH CITRULLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NG, NG-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DIMETHYLARGININASE-1, DIMETHYLARGININE COMPND 5 DIMETHYLAMINOHYDROLASE 1, DDAHI, DDAH-1; COMPND 6 EC: 3.5.3.18; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: B834(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS DDAH, HYDROLASE, NITRIC OXIDE SYNTHASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.MURRAY-RUST,B.P.O'HARA,S.ROSSITER,J.M.LEIPER,P.VALLANCE, AUTHOR 2 N.Q.MCDONALD REVDAT 7 15-NOV-23 2JAI 1 ATOM REVDAT 6 08-MAY-19 2JAI 1 REMARK LINK REVDAT 5 28-FEB-18 2JAI 1 SOURCE AUTHOR JRNL REVDAT 4 13-JUL-11 2JAI 1 VERSN REVDAT 3 24-FEB-09 2JAI 1 VERSN REVDAT 2 27-FEB-07 2JAI 1 REMARK REVDAT 1 13-FEB-07 2JAI 0 JRNL AUTH J.LEIPER,M.NANDI,B.TORONDEL,J.MURRAY-RUST,M.MALAKI,B.O'HARA, JRNL AUTH 2 S.ROSSITER,S.ANTHONY,M.MADHANI,D.SELWOOD,C.SMITH, JRNL AUTH 3 B.WOJCIAK-STOTHARD,A.RUDIGER,R.STIDWILL,N.Q.MCDONALD, JRNL AUTH 4 P.VALLANCE JRNL TITL DISRUPTION OF METHYLARGININE METABOLISM IMPAIRS VASCULAR JRNL TITL 2 HOMEOSTASIS. JRNL REF NAT. MED. V. 13 198 2007 JRNL REFN ISSN 1078-8956 JRNL PMID 17273169 JRNL DOI 10.1038/NM1543 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 3 NUMBER OF REFLECTIONS : 24273 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1301 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1101 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1630 REMARK 3 BIN FREE R VALUE SET COUNT : 59 REMARK 3 BIN FREE R VALUE : 0.2540 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3901 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 125 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.17000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : -2.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.28000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.337 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.253 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.156 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.091 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.877 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3992 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5432 ; 1.520 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 539 ; 6.618 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 141 ;37.428 ;24.184 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 609 ;14.338 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;14.765 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 663 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2961 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1708 ; 0.199 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2708 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 214 ; 0.150 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.216 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.204 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2778 ; 0.712 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4287 ; 1.022 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1336 ; 1.863 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1143 ; 2.756 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 8 A 280 6 REMARK 3 1 B 8 B 280 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 A (A): 1791 ; 0.29 ; 5.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 1791 ; 2.11 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 8 A 280 REMARK 3 ORIGIN FOR THE GROUP (A): 17.0980 -0.3160 55.9580 REMARK 3 T TENSOR REMARK 3 T11: -0.3279 T22: -0.1889 REMARK 3 T33: -0.1201 T12: 0.0015 REMARK 3 T13: 0.0506 T23: -0.0074 REMARK 3 L TENSOR REMARK 3 L11: 1.3649 L22: 1.8200 REMARK 3 L33: 2.3059 L12: 0.2191 REMARK 3 L13: 0.1159 L23: -0.1347 REMARK 3 S TENSOR REMARK 3 S11: 0.0168 S12: 0.1234 S13: -0.0138 REMARK 3 S21: -0.0672 S22: 0.0674 S23: -0.0322 REMARK 3 S31: 0.0257 S32: 0.0436 S33: -0.0842 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 5 B 280 REMARK 3 ORIGIN FOR THE GROUP (A): 7.2670 24.7080 15.6890 REMARK 3 T TENSOR REMARK 3 T11: 0.2424 T22: 0.1168 REMARK 3 T33: -0.0811 T12: -0.2186 REMARK 3 T13: -0.0585 T23: 0.0841 REMARK 3 L TENSOR REMARK 3 L11: 1.8111 L22: 5.6965 REMARK 3 L33: 9.2580 L12: -1.5100 REMARK 3 L13: 1.9065 L23: -2.9830 REMARK 3 S TENSOR REMARK 3 S11: -0.0303 S12: 0.2150 S13: 0.1411 REMARK 3 S21: -0.2901 S22: -0.3380 S23: -0.2812 REMARK 3 S31: -0.4642 S32: 0.7463 S33: 0.3682 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2JAI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1290030469. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9330 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25580 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 7.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.08000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 20MG/ML IN 20MM TRIS-HCL PH REMARK 280 8.0, 150MM NACL, 1MM DTT PRECIPITANT: 50MM TRIS-HCL PH 8.5, 150- REMARK 280 300MM SODIUM ACETATE, 20-30% W/V PEG4000, 1MM DTT CO- REMARK 280 CRYSTALLISED WITH 10MM LIGAND IN PRECIPITATING SOLUTION EXPT: REMARK 280 SITTING DROPS UNDER MINERAL OIL AT 16DEG C, MICROBATCH, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 23.39950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 MSE A 0 REMARK 465 ALA A 1 REMARK 465 GLY A 2 REMARK 465 LEU A 3 REMARK 465 GLY A 4 REMARK 465 HIS A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 168 REMARK 465 ASP A 169 REMARK 465 LYS A 281 REMARK 465 VAL A 282 REMARK 465 ASP A 283 REMARK 465 SER A 284 REMARK 465 ASP B 120 REMARK 465 GLU B 121 REMARK 465 ARG B 135 REMARK 465 GLU B 136 REMARK 465 ALA B 168 REMARK 465 ASP B 169 REMARK 465 GLY B 170 REMARK 465 GLY B 188 REMARK 465 SER B 189 REMARK 465 SER B 204 REMARK 465 ASP B 205 REMARK 465 HIS B 206 REMARK 465 GLU B 240 REMARK 465 TYR B 241 REMARK 465 LYS B 281 REMARK 465 VAL B 282 REMARK 465 ASP B 283 REMARK 465 SER B 284 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 11 CD NE CZ NH1 NH2 REMARK 470 LYS A 33 CG CD CE NZ REMARK 470 GLN A 60 CG CD OE1 NE2 REMARK 470 LYS A 99 CG CD CE NZ REMARK 470 GLU A 106 CG CD OE1 OE2 REMARK 470 GLU A 121 CD OE1 OE2 REMARK 470 ARG A 135 NE CZ NH1 NH2 REMARK 470 LYS A 143 CD CE NZ REMARK 470 LYS A 195 CG CD CE NZ REMARK 470 LYS A 198 CE NZ REMARK 470 GLN A 201 OE1 NE2 REMARK 470 LYS A 210 CG CD CE NZ REMARK 470 GLU A 239 OE1 OE2 REMARK 470 GLU A 249 CD OE1 OE2 REMARK 470 LYS A 250 CG CD CE NZ REMARK 470 LYS A 252 CD CE NZ REMARK 470 LYS A 280 CG CD CE NZ REMARK 470 MSE B 0 CG SE CE REMARK 470 SER B 31 OG REMARK 470 LYS B 33 CG CD CE NZ REMARK 470 GLU B 35 CG CD OE1 OE2 REMARK 470 GLU B 43 OE1 OE2 REMARK 470 LYS B 56 CG CD CE NZ REMARK 470 GLN B 60 CD OE1 NE2 REMARK 470 GLU B 84 CG CD OE1 OE2 REMARK 470 GLU B 85 CG CD OE1 OE2 REMARK 470 ARG B 91 CD NE CZ NH1 NH2 REMARK 470 LYS B 99 CG CD CE NZ REMARK 470 ASP B 102 CG OD1 OD2 REMARK 470 LYS B 105 CG CD CE NZ REMARK 470 GLU B 106 CG CD OE1 OE2 REMARK 470 LYS B 110 CD CE NZ REMARK 470 ASN B 114 CG OD1 ND2 REMARK 470 LYS B 119 CG CD CE NZ REMARK 470 LYS B 143 CG CD CE NZ REMARK 470 GLN B 147 CG CD OE1 NE2 REMARK 470 ARG B 148 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 151 CG CD OE1 OE2 REMARK 470 ASP B 155 CG OD1 OD2 REMARK 470 LYS B 158 CG CD CE NZ REMARK 470 ASP B 159 CG OD1 OD2 REMARK 470 LEU B 171 CG CD1 CD2 REMARK 470 LYS B 174 CE NZ REMARK 470 ILE B 187 CG1 CG2 CD1 REMARK 470 GLU B 191 CG CD OE1 OE2 REMARK 470 SER B 192 OG REMARK 470 GLN B 194 CG CD OE1 NE2 REMARK 470 LYS B 195 CG CD CE NZ REMARK 470 LYS B 198 CG CD CE NZ REMARK 470 ILE B 199 CG1 CG2 CD1 REMARK 470 GLN B 201 CG CD OE1 NE2 REMARK 470 GLN B 202 CG CD OE1 NE2 REMARK 470 ARG B 207 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 209 CG OD1 OD2 REMARK 470 LYS B 210 CG CD CE NZ REMARK 470 LEU B 211 CG CD1 CD2 REMARK 470 VAL B 213 CG1 CG2 REMARK 470 ASP B 215 CG OD1 OD2 REMARK 470 ILE B 217 CG1 CG2 CD1 REMARK 470 LYS B 229 CG CD CE NZ REMARK 470 THR B 237 OG1 CG2 REMARK 470 GLU B 239 CG CD OE1 OE2 REMARK 470 GLU B 243 CG CD OE1 OE2 REMARK 470 LYS B 246 CG CD CE NZ REMARK 470 GLU B 249 CG CD OE1 OE2 REMARK 470 LYS B 250 CG CD CE NZ REMARK 470 LYS B 252 CG CD CE NZ REMARK 470 ASP B 253 CG OD1 OD2 REMARK 470 SER B 260 OG REMARK 470 LYS B 280 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASN B 122 CG ASN B 122 OD1 0.190 REMARK 500 ASN B 122 CG ASN B 122 ND2 0.223 REMARK 500 ASN B 122 C ALA B 123 N 0.160 REMARK 500 ASN B 146 CG ASN B 146 OD1 0.215 REMARK 500 ASN B 146 CG ASN B 146 ND2 0.244 REMARK 500 LYS B 158 C LYS B 158 O 0.114 REMARK 500 ARG B 207 N ARG B 207 CA 0.124 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 84 -114.67 55.04 REMARK 500 SER A 142 -157.63 -130.29 REMARK 500 PHE A 157 69.60 -108.54 REMARK 500 PHE A 176 12.87 -140.18 REMARK 500 ASN A 228 -8.32 77.49 REMARK 500 MSE A 261 34.50 -142.27 REMARK 500 LEU A 270 -161.74 -129.78 REMARK 500 LEU B 70 78.00 -118.60 REMARK 500 GLU B 84 -117.06 55.99 REMARK 500 PHE B 157 59.04 -105.00 REMARK 500 PHE B 176 10.44 -142.23 REMARK 500 ASN B 183 18.20 59.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIR A1281 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H70 RELATED DB: PDB REMARK 900 DDAH FROM PSEUDOMONAS AERUGINOSA. C249S MUTANT COMPLEXED WITH REMARK 900 CITRULLINE REMARK 900 RELATED ID: 2JAJ RELATED DB: PDB REMARK 900 DDAH1 COMPLEXED WITH L-257 REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL VECTOR-DERIVED SEQUENCE GPLGM IN CHAIN B DBREF 2JAI A -4 0 PDB 2JAI 2JAI -4 0 DBREF 2JAI A 1 284 UNP O94760 DDAH1_HUMAN 1 284 DBREF 2JAI B -4 0 PDB 2JAI 2JAI -4 0 DBREF 2JAI B 1 284 UNP O94760 DDAH1_HUMAN 1 284 SEQRES 1 A 289 GLY PRO LEU GLY MSE ALA GLY LEU GLY HIS PRO ALA ALA SEQRES 2 A 289 PHE GLY ARG ALA THR HIS ALA VAL VAL ARG ALA LEU PRO SEQRES 3 A 289 GLU SER LEU GLY GLN HIS ALA LEU ARG SER ALA LYS GLY SEQRES 4 A 289 GLU GLU VAL ASP VAL ALA ARG ALA GLU ARG GLN HIS GLN SEQRES 5 A 289 LEU TYR VAL GLY VAL LEU GLY SER LYS LEU GLY LEU GLN SEQRES 6 A 289 VAL VAL GLU LEU PRO ALA ASP GLU SER LEU PRO ASP CYS SEQRES 7 A 289 VAL PHE VAL GLU ASP VAL ALA VAL VAL CYS GLU GLU THR SEQRES 8 A 289 ALA LEU ILE THR ARG PRO GLY ALA PRO SER ARG ARG LYS SEQRES 9 A 289 GLU VAL ASP MSE MSE LYS GLU ALA LEU GLU LYS LEU GLN SEQRES 10 A 289 LEU ASN ILE VAL GLU MSE LYS ASP GLU ASN ALA THR LEU SEQRES 11 A 289 ASP GLY GLY ASP VAL LEU PHE THR GLY ARG GLU PHE PHE SEQRES 12 A 289 VAL GLY LEU SER LYS ARG THR ASN GLN ARG GLY ALA GLU SEQRES 13 A 289 ILE LEU ALA ASP THR PHE LYS ASP TYR ALA VAL SER THR SEQRES 14 A 289 VAL PRO VAL ALA ASP GLY LEU HIS LEU LYS SER PHE CYS SEQRES 15 A 289 SER MSE ALA GLY PRO ASN LEU ILE ALA ILE GLY SER SER SEQRES 16 A 289 GLU SER ALA GLN LYS ALA LEU LYS ILE MSE GLN GLN MSE SEQRES 17 A 289 SER ASP HIS ARG TYR ASP LYS LEU THR VAL PRO ASP ASP SEQRES 18 A 289 ILE ALA ALA ASN CYS ILE TYR LEU ASN ILE PRO ASN LYS SEQRES 19 A 289 GLY HIS VAL LEU LEU HIS ARG THR PRO GLU GLU TYR PRO SEQRES 20 A 289 GLU SER ALA LYS VAL TYR GLU LYS LEU LYS ASP HIS MSE SEQRES 21 A 289 LEU ILE PRO VAL SER MSE SER GLU LEU GLU LYS VAL ASP SEQRES 22 A 289 GLY LEU LEU THR CYS CYS SER VAL LEU ILE ASN LYS LYS SEQRES 23 A 289 VAL ASP SER SEQRES 1 B 289 GLY PRO LEU GLY MSE ALA GLY LEU GLY HIS PRO ALA ALA SEQRES 2 B 289 PHE GLY ARG ALA THR HIS ALA VAL VAL ARG ALA LEU PRO SEQRES 3 B 289 GLU SER LEU GLY GLN HIS ALA LEU ARG SER ALA LYS GLY SEQRES 4 B 289 GLU GLU VAL ASP VAL ALA ARG ALA GLU ARG GLN HIS GLN SEQRES 5 B 289 LEU TYR VAL GLY VAL LEU GLY SER LYS LEU GLY LEU GLN SEQRES 6 B 289 VAL VAL GLU LEU PRO ALA ASP GLU SER LEU PRO ASP CYS SEQRES 7 B 289 VAL PHE VAL GLU ASP VAL ALA VAL VAL CYS GLU GLU THR SEQRES 8 B 289 ALA LEU ILE THR ARG PRO GLY ALA PRO SER ARG ARG LYS SEQRES 9 B 289 GLU VAL ASP MSE MSE LYS GLU ALA LEU GLU LYS LEU GLN SEQRES 10 B 289 LEU ASN ILE VAL GLU MSE LYS ASP GLU ASN ALA THR LEU SEQRES 11 B 289 ASP GLY GLY ASP VAL LEU PHE THR GLY ARG GLU PHE PHE SEQRES 12 B 289 VAL GLY LEU SER LYS ARG THR ASN GLN ARG GLY ALA GLU SEQRES 13 B 289 ILE LEU ALA ASP THR PHE LYS ASP TYR ALA VAL SER THR SEQRES 14 B 289 VAL PRO VAL ALA ASP GLY LEU HIS LEU LYS SER PHE CYS SEQRES 15 B 289 SER MSE ALA GLY PRO ASN LEU ILE ALA ILE GLY SER SER SEQRES 16 B 289 GLU SER ALA GLN LYS ALA LEU LYS ILE MSE GLN GLN MSE SEQRES 17 B 289 SER ASP HIS ARG TYR ASP LYS LEU THR VAL PRO ASP ASP SEQRES 18 B 289 ILE ALA ALA ASN CYS ILE TYR LEU ASN ILE PRO ASN LYS SEQRES 19 B 289 GLY HIS VAL LEU LEU HIS ARG THR PRO GLU GLU TYR PRO SEQRES 20 B 289 GLU SER ALA LYS VAL TYR GLU LYS LEU LYS ASP HIS MSE SEQRES 21 B 289 LEU ILE PRO VAL SER MSE SER GLU LEU GLU LYS VAL ASP SEQRES 22 B 289 GLY LEU LEU THR CYS CYS SER VAL LEU ILE ASN LYS LYS SEQRES 23 B 289 VAL ASP SER MODRES 2JAI MSE A 103 MET SELENOMETHIONINE MODRES 2JAI MSE A 104 MET SELENOMETHIONINE MODRES 2JAI MSE A 118 MET SELENOMETHIONINE MODRES 2JAI MSE A 179 MET SELENOMETHIONINE MODRES 2JAI MSE A 200 MET SELENOMETHIONINE MODRES 2JAI MSE A 203 MET SELENOMETHIONINE MODRES 2JAI MSE A 255 MET SELENOMETHIONINE MODRES 2JAI MSE A 261 MET SELENOMETHIONINE MODRES 2JAI MSE B 0 MET SELENOMETHIONINE MODRES 2JAI MSE B 103 MET SELENOMETHIONINE MODRES 2JAI MSE B 104 MET SELENOMETHIONINE MODRES 2JAI MSE B 118 MET SELENOMETHIONINE MODRES 2JAI MSE B 179 MET SELENOMETHIONINE MODRES 2JAI MSE B 200 MET SELENOMETHIONINE MODRES 2JAI MSE B 203 MET SELENOMETHIONINE MODRES 2JAI MSE B 255 MET SELENOMETHIONINE MODRES 2JAI MSE B 261 MET SELENOMETHIONINE HET MSE A 103 13 HET MSE A 104 8 HET MSE A 118 8 HET MSE A 179 8 HET MSE A 200 8 HET MSE A 203 8 HET MSE A 255 8 HET MSE A 261 8 HET MSE B 0 5 HET MSE B 103 8 HET MSE B 104 8 HET MSE B 118 8 HET MSE B 179 8 HET MSE B 200 8 HET MSE B 203 8 HET MSE B 255 8 HET MSE B 261 8 HET CIR A1281 12 HETNAM MSE SELENOMETHIONINE HETNAM CIR CITRULLINE FORMUL 1 MSE 17(C5 H11 N O2 SE) FORMUL 3 CIR C6 H13 N3 O3 FORMUL 4 HOH *125(H2 O) HELIX 1 1 SER A 23 ALA A 28 1 6 HELIX 2 2 ASP A 38 SER A 55 1 18 HELIX 3 3 PHE A 75 ASP A 78 5 4 HELIX 4 4 ALA A 94 LYS A 99 5 6 HELIX 5 5 GLU A 100 LEU A 111 1 12 HELIX 6 6 ASP A 126 GLY A 128 5 3 HELIX 7 7 ASN A 146 PHE A 157 1 12 HELIX 8 8 HIS A 172 SER A 175 5 4 HELIX 9 9 SER A 190 MSE A 203 1 14 HELIX 10 10 ASP A 216 ASN A 220 5 5 HELIX 11 11 TYR A 241 GLU A 249 1 9 HELIX 12 12 MSE A 261 LYS A 266 1 6 HELIX 13 13 LEU A 271 SER A 275 5 5 HELIX 14 14 SER B 23 ALA B 28 1 6 HELIX 15 15 ASP B 38 SER B 55 1 18 HELIX 16 16 PHE B 75 ASP B 78 5 4 HELIX 17 17 ALA B 94 ARG B 98 5 5 HELIX 18 18 LYS B 99 LEU B 111 1 13 HELIX 19 19 ASP B 126 GLY B 128 5 3 HELIX 20 20 ASN B 146 PHE B 157 1 12 HELIX 21 21 HIS B 172 PHE B 176 5 5 HELIX 22 22 SER B 192 MSE B 203 1 12 HELIX 23 23 ASP B 215 ASN B 220 5 6 HELIX 24 24 SER B 244 GLU B 249 1 6 HELIX 25 25 MSE B 261 LYS B 266 1 6 HELIX 26 26 LEU B 271 SER B 275 5 5 SHEET 1 AA 3 GLN A 60 LEU A 64 0 SHEET 2 AA 3 HIS A 14 ARG A 18 1 O ALA A 15 N VAL A 62 SHEET 3 AA 3 VAL A 276 ILE A 278 -1 O VAL A 276 N VAL A 16 SHEET 1 AB 3 ALA A 80 CYS A 83 0 SHEET 2 AB 3 THR A 86 ILE A 89 -1 O THR A 86 N CYS A 83 SHEET 3 AB 3 ASN A 114 GLU A 117 1 O ASN A 114 N ALA A 87 SHEET 1 AC 4 VAL A 130 PHE A 132 0 SHEET 2 AC 4 GLU A 136 LEU A 141 -1 O PHE A 138 N LEU A 131 SHEET 3 AC 4 ALA A 161 PRO A 166 1 O ALA A 161 N PHE A 137 SHEET 4 AC 4 PRO B -3 LEU B -2 -1 O LEU B -2 N VAL A 162 SHEET 1 AD 3 CYS A 177 GLY A 181 0 SHEET 2 AD 3 LEU A 184 ILE A 187 -1 O LEU A 184 N ALA A 180 SHEET 3 AD 3 ASP A 209 THR A 212 1 O ASP A 209 N ILE A 185 SHEET 1 AE 3 ILE A 222 ILE A 226 0 SHEET 2 AE 3 GLY A 230 HIS A 235 -1 O GLY A 230 N ILE A 226 SHEET 3 AE 3 HIS A 254 PRO A 258 1 O MSE A 255 N LEU A 233 SHEET 1 BA 3 GLN B 60 LEU B 64 0 SHEET 2 BA 3 HIS B 14 ARG B 18 1 O ALA B 15 N VAL B 62 SHEET 3 BA 3 VAL B 276 ILE B 278 -1 O VAL B 276 N VAL B 16 SHEET 1 BB 3 ALA B 80 CYS B 83 0 SHEET 2 BB 3 THR B 86 ILE B 89 -1 O THR B 86 N CYS B 83 SHEET 3 BB 3 ASN B 114 GLU B 117 1 O ASN B 114 N ALA B 87 SHEET 1 BC 3 VAL B 130 LEU B 131 0 SHEET 2 BC 3 PHE B 138 LEU B 141 -1 O PHE B 138 N LEU B 131 SHEET 3 BC 3 SER B 163 PRO B 166 1 O SER B 163 N VAL B 139 SHEET 1 BD 3 SER B 178 GLY B 181 0 SHEET 2 BD 3 LEU B 184 ILE B 187 -1 O LEU B 184 N ALA B 180 SHEET 3 BD 3 ASP B 209 THR B 212 1 O ASP B 209 N ILE B 185 SHEET 1 BE 3 ILE B 222 ILE B 226 0 SHEET 2 BE 3 GLY B 230 ARG B 236 -1 O GLY B 230 N ILE B 226 SHEET 3 BE 3 HIS B 254 VAL B 259 1 O MSE B 255 N LEU B 233 LINK C ASP A 102 N MSE A 103 1555 1555 1.33 LINK C MSE A 103 N MSE A 104 1555 1555 1.33 LINK C MSE A 104 N LYS A 105 1555 1555 1.33 LINK C GLU A 117 N MSE A 118 1555 1555 1.33 LINK C MSE A 118 N LYS A 119 1555 1555 1.32 LINK C SER A 178 N MSE A 179 1555 1555 1.32 LINK C MSE A 179 N ALA A 180 1555 1555 1.34 LINK C ILE A 199 N MSE A 200 1555 1555 1.34 LINK C MSE A 200 N GLN A 201 1555 1555 1.34 LINK C GLN A 202 N MSE A 203 1555 1555 1.33 LINK C MSE A 203 N SER A 204 1555 1555 1.32 LINK C HIS A 254 N MSE A 255 1555 1555 1.33 LINK C MSE A 255 N LEU A 256 1555 1555 1.33 LINK C SER A 260 N MSE A 261 1555 1555 1.32 LINK C MSE A 261 N SER A 262 1555 1555 1.34 LINK SG ACYS A 273 O7 CIR A1281 1555 1555 1.85 LINK C GLY B -1 N MSE B 0 1555 1555 1.34 LINK C MSE B 0 N ALA B 1 1555 1555 1.33 LINK C ASP B 102 N MSE B 103 1555 1555 1.33 LINK C MSE B 103 N MSE B 104 1555 1555 1.34 LINK C MSE B 104 N LYS B 105 1555 1555 1.33 LINK C GLU B 117 N MSE B 118 1555 1555 1.34 LINK C MSE B 118 N LYS B 119 1555 1555 1.33 LINK C SER B 178 N MSE B 179 1555 1555 1.34 LINK C MSE B 179 N ALA B 180 1555 1555 1.33 LINK C ILE B 199 N MSE B 200 1555 1555 1.34 LINK C MSE B 200 N GLN B 201 1555 1555 1.34 LINK C GLN B 202 N MSE B 203 1555 1555 1.35 LINK C HIS B 254 N MSE B 255 1555 1555 1.33 LINK C MSE B 255 N LEU B 256 1555 1555 1.33 LINK C SER B 260 N MSE B 261 1555 1555 1.33 LINK C MSE B 261 N SER B 262 1555 1555 1.33 SITE 1 AC1 13 LEU A 29 ASP A 72 GLU A 77 ASP A 78 SITE 2 AC1 13 ARG A 97 GLY A 128 ARG A 144 HIS A 172 SITE 3 AC1 13 VAL A 267 ASP A 268 LEU A 270 CYS A 273 SITE 4 AC1 13 HOH A2114 CRYST1 44.831 46.799 147.787 90.00 94.64 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022306 0.000000 0.001810 0.00000 SCALE2 0.000000 0.021368 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006789 0.00000 MTRIX1 1 -0.871000 -0.043000 -0.489000 50.21154 1 MTRIX2 1 -0.041000 0.999000 -0.015000 27.15460 1 MTRIX3 1 0.489000 0.007000 -0.872000 56.20957 1